Stock Comparison
LLY vs NVS
Eli Lilly and Company and Novartis AG ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$1.08T
$296.54B
P/E (TTM)
42.9
22.3
Forward P/E
31.1
17.6
Price/Sales
14.9
5.2
Price/Book
32.2
7.7
EV/EBITDA
28.8
15.1
Dividend Yield
0.55%
3.05%
Profitability
Net Margin
35.00%
23.90%
Operating Margin
49.40%
30.50%
Return on Equity
107.50%
34.90%
Return on Assets
20.70%
10.50%
Growth (YoY)
Revenue Growth
55.50%
-0.70%
Earnings Growth
169.90%
-9.30%
Price & Risk
Beta
0.5
0.5
52-Week High
$1,215.76
$165.43
52-Week Low
$619.40
$109.02
Analyst Target
$1,222.62
$153.87
Compare LLY and NVS your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.